1. |
殷蔚伯, 余子豪, 徐国镇, 等. 肿瘤放射治疗学. 北京:中国协和医科大学出版社, 2007. 546.
|
2. |
Schoppmann SF, Asari R, Riegler M. Barrett's esophagus as a marker for increased risk for esophageal cancer and cardiorespiratory disease. Endoscopy, 2013, 45(2):152.
|
3. |
居来提·艾尼瓦尔, 李德生, 张力为, 等. 2005~2008 年伊犁地区食管癌患病情况调查研究. 新疆医学, 2011, 41:112-114.
|
4. |
Gridelli C, Rossi A. Malone P. Non-small cell lung cancer. New antiangiogenetic agents and non-small cell lung cancer. Cat Rev Oncol Hemat, 2006, 60(1):76-86.
|
5. |
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med, 2003, 9(6):669-676.
|
6. |
Donnem T, AI-Shibli K, Andersen S, et al. Combination of low vascular endothelial growth factor A(VEGF-A)/VEGF receptor.
|
7. |
expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with non small cell lung cancer. Cancer, 2010, l 16(18):4318-4325.
|
8. |
Ghosh S, Sullivan CA, Zerkowski MP, et al. High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1)are associated with worse outcome in breast cancer. Hum Pathol, 2008, 39(12):1835-1843.
|
9. |
张莹, 蒋晓东, 乔云, 等. 不同肺癌细胞株中 VEGFR-2 mRNA 表达的实验研究. 临床肿瘤学杂志, 2013, 18(10):879-881.
|
10. |
Sinicrope FA, Ruan SB, Cleary KR, et al. Bcl-2 and p53 oncoprotein expression during colorectal tu morigenesis. Cancer Res, 1995, 55(2):237-241.
|
11. |
Ranieri G, Patruno R, Ruggieri E, et al.Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer:from the biology to the clinic. Curr Med Chem, 2006, 13(16):B1 845.
|
12. |
Al-Moundhri MS, Al-Shukaili A, Al-Nabhani M. Measurement of circulating levels of VEGF-A, -C and -D and their receptor, VEGFR-1 and-2 in gastric adenocarcinoma. World J Gastroenterol, 2008, 14(24):3879-3883.
|
13. |
Yoshiji H, Kuriyama S, Noguchi R, et al. Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice. Gut, 2005, 54(12):1768-1775.
|
14. |
Scharpfenecker M, Fiedler U, Reiss Y, et al. The Tie 2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci, 2005, 118(Pt 4):771-780.
|
15. |
蒋晓东, 戴鹏, 宋大安, 等. HIF-1α、VEGF、VEGFR-2 在非小细胞肺癌组织中的表达及临床意义. 临床肺科杂志, 2011, 16(3):386-388.
|
16. |
蒙玉刚, 梁春燕, 曾雅畅, 等. 血管内皮生长因子 A 及其受体VEGFR-2 在宫颈癌血清中的表达及其临床意义. 广西医科大学学报, 2013, 30(1):45-47.
|
17. |
李新春, 李新国. NK、VEGF-A 在原发性输卵管腺癌中的表达及其意义. 实用预防医学, 2010, 17(6):1065-1066.
|
18. |
樊晴伶, 尹一童. 血管内皮生长因子与胃癌转移及预后的研究进展. 中国实用医药, 2009, 4(24):248-249.
|
19. |
Mohammde RA, Green A, El-shikhs, et al. Prognostic significance of vascular endothelial cell growth factor -A,-C, and -D in breast cancer and their relationship with angio-and lymphangio-genesis. Br J Cancer, 2007, 96(7):1092-1100.
|